Geron Corporation (NASDAQ: GERN) closed the day trading at $2.21 down -3.91% from the previous closing price of $2.30. In other words, the price has decreased by -$0.0900 from its previous closing price. On the day, 19020016 shares were traded. GERN stock price reached its highest trading level at $2.3150 during the session, while it also had its lowest trading level at $2.1800.
For a better understanding of GERN, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.20 and its Current Ratio is at 5.20. In the meantime, Its Debt-to-Equity ratio is 0.17 whereas as Long-Term Debt/Eq ratio is at 0.14.
Upgrades & Downgrades
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 24 when O’Farrell Elizabeth G. bought 6,607 shares for $2.28 per share. The transaction valued at 15,064 led to the insider holds 7,407 shares of the business.
O’Farrell Elizabeth G. bought 6,579 shares of GERN for $15,000 on Aug 24. The Director now owns 26,220 shares after completing the transaction at $2.28 per share. On May 11, another insider, LAWLIS V BRYAN, who serves as the Director of the company, sold 35,000 shares for $3.00 each. As a result, the insider received 105,000 and left with 0 shares of the company.
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GERN now has a Market Capitalization of 1.16B and an Enterprise Value of 841.20M. For the stock, the TTM Price-to-Sale (P/S) ratio is 2407.62 while its Price-to-Book (P/B) ratio in mrq is 4.02. Its current Enterprise Value per Revenue stands at 1.87k whereas that against EBITDA is -5.18.
Stock Price History:
Over the past 52 weeks, GERN has reached a high of $3.84, while it has fallen to a 52-week low of $1.95. The 50-Day Moving Average of the stock is 2.7984, while the 200-Day Moving Average is calculated to be 2.7662.
Over the past 3-months, GERN traded about 5.37M shares per day on average, while over the past 10 days, GERN traded about 8.15M shares per day. A total of 547.28M shares are outstanding, with a floating share count of 522.32M. Insiders hold about 0.10% of the company’s shares, while institutions hold 50.50% stake in the company. Shares short for GERN as of Aug 30, 2023 were 33.29M with a Short Ratio of 33.29M, compared to 26.95M on Jul 30, 2023. Therefore, it implies a Short% of Shares Outstanding of 6.36% and a Short% of Float of 6.39%.
Current recommendations for the stock of the company come from 6 analysts. On average, analysts expect EPS of -$0.1 for the current quarter, with a high estimate of -$0.09 and a low estimate of -$0.12, while EPS last year was -$0.1. The consensus estimate for the next quarter is -$0.11, with high estimates of -$0.1 and low estimates of -$0.13.
Analysts are recommending an EPS of between -$0.35 and -$0.41 for the fiscal current year, implying an average EPS of -$0.37. EPS for the following year is -$0.36, with 6 analysts recommending between -$0.22 and -$0.49.
A total of 6 analysts have provided revenue estimates for GERN’s current fiscal year. The highest revenue estimate was $350k, while the lowest revenue estimate was $50k, resulting in an average revenue estimate of $170k. In the same quarter a year ago, actual revenue was $596k, down -71.50% from the average estimate. Based on 5 analysts’ estimates, the company’s revenue will be $79.03M in the next fiscal year. The high estimate is $116.87M and the low estimate is $40.27M. The average revenue growth estimate for next year is up 46,388.20% from the average revenue estimate for this year.